Info Tooltip

Premium Info (Not Yet Available)

Free: 3 months of data free.
Premium: Longer timeframes, improved filtering tools, no ads.

Most Recent 50 'COVID' Related ASX Announcements

These results are the type of thing you could search for in the Announcements Filter tool. In this case, we've searched for 'COVID' while 'COVID + Clinical Trial' could be a similarly interesting search.
Market SensitiveDateCompanyAnnouncement
Yes 26 Nov ANO COVID-19 Sales Update
26 Nov HCT HCT Advances TGA Application on NatShield COVID-19 Labelling
Yes 25 Nov ADO AnteoTech Freeze Design of COVID 19 Test
Yes 22 Nov TYR COVID-19 Trading Update 36 - Week Ended 20 November 2020
Yes 19 Nov NSB NSB to investigate treatment for post-COVID Fibrosis
Yes 15 Nov TYR COVID-19 Trading Update 35 - Week Ended 13 November 2020
Yes 10 Nov MSB DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
10 Nov CBA COVID-19 Temporary Loan Repayment Deferrals October 2020
Yes 08 Nov DXB ARDS in COVID-19 Patients Protocol Published
Yes 08 Nov TYR COVID-19 Trading Update 34 - Week Ended 6 November 2020
04 Nov NOX NOXCOVID Study Cleared To Expand
Yes 03 Nov PGC Company Update - Business Impacts of COVID-19
Yes 02 Nov ABA Strong Q1 FY2021 and COVID-19 update
Yes 01 Nov TYR COVID-19 Trading Update 33 - Week Ended 30 October 2020
Yes 28 Oct MSB COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C
Yes 27 Oct AT1 Atomo receives TGA approval for COVID19 antigen test
26 Oct BEN Update on 1Q21 trading result & COVID-19 support packages
25 Oct NOX First Two Cohorts Enrolled in NOXCOVID Study
Yes 25 Oct TYR COVID-19 Trading Update 32 - Week Ended 23 October 2020
Yes 22 Oct IMM COVID-19 phase 2 investigator initiated trial commences
Yes 21 Oct ADO Study Confirms Targeted Sensitivity of COVID-19 Test
20 Oct YPB Connect platform to provide COVID-19 contact tracing
Yes 18 Oct TYR COVID-19 Trading Update 31 - Week Ended 16 October 2020
Yes 13 Oct PFP Trading Update and COVID-19 Impacts
09 Oct NOX Noxopharm CMO Discusses the NOXCOVID trial
Yes 08 Oct PYG First Half FY21 Trading and COVID 19 update
Yes 05 Oct TYR COVID-19 Trading Update 29 - Week Ended 2 October 2020
02 Oct XTD Annual General Meeting - Notice of Access & COVID-19 Warning
Yes 02 Oct NOX First COVID-19 Patient Treated in Veyonda Study
Yes 01 Oct ELS Update on Business operations during the COVID-19 Pandemic
Yes 28 Sep TYR COVID-19 Trading Update 28 - Week Ended 25 September 2020
Yes 24 Sep PAA PAA Evaluate MPL Suitability for Ex-Vivo Human COVID-19 Test
Yes 23 Sep AT1 DIVOC Labs to sell Atomo's COVID-19 test in India
Yes 21 Sep ANO COVID-19 Sales Update
Yes 21 Sep TYR COVID-19 Trading Update 27 - Week Ended 18 September 2020
Yes 14 Sep SPL SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
Yes 14 Sep TYR COVID-19 Trading Update 26 - Week Ended 11 September 2020
10 Sep SUN APRA COVID-19 temporary loan repayment deferral data
Yes 09 Sep ADO AnteoTech COVID-19 Antigen Test Progress Update
09 Sep CYC CYC Partners With McMasters University In COVID-19 Research
Yes 08 Sep RCE Positive & Concentration-Dependent Efficacy Against COVID-19
Yes 07 Sep TYR COVID-19 Trading Update 25 - Week Ended 4 September 2020
07 Sep CSL Agreements to Manufacture COVID-19 Vaccines
Yes 04 Sep MSB DSMB Recommends Continuation of Phase 3 COVID-19 Trial
Yes 03 Sep SPL Starpharma awarded $1M MRFF funding for COVID-19 spray
02 Sep MSB Ethics Approval to Treat COVID-19 Patients in Australia
01 Sep RAP Continued Use of ResAppDx at COVID-19 Respiratory Clinic
Yes 01 Sep NOX Veyonda COVID-19 Study Approved For Immediate Start